Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
09997 Kangji Medical Holdings
8.110
+0.120+1.50%
Symbol
09997
Company Name
Kangji Medical Holdings
ISIN
KYG5215A1004
Listing Date
06/29/2020
Establishment Date
02/12/2020
Registration
Cayman Islands
Chairman
Ming Zhong
Secretary
Zhaoqiang Wen
Audit Institution
Ernst & Young accounting firm
Company Category
Overseas registration of Mainland Individuals control
Registered Office
Maples Corporate Services Limited P.O. Box 309 Ugland House Grand Cayman KY1-1104 Cayman Islands
Head Office and Principal Place of Business
Room 1007B, 10 / F, Hong Kong Crystal Centre, 100 Granville Road, Kowloon, Hong Kong
Fiscal Year Ends
12-31
Employees
846
Market
Hong Kong motherboard
Phone
(86)57169900020
Email
ir@hzkangji.com
Business
Kangji Medical Holdings Co., Ltd. is a Chinese investment holding company mainly engaged in the design, development, manufacture and sales of minimally invasive surgical instruments and accessories. The company's main products include disposable casing puncture devices, polymer ligation clips, disposable electrocoagulation forceps and other disposable products, which are used in obstetrics and gynecology, urology, general surgery and thoracic surgery. The company's products are sold to domestic and foreign markets.
Profile
The Group was founded in August 2004 in Hangzhou Kangji Medical equipment Co., Ltd. ("Hangzhou Kangji", "Company"). Hangzhou Kangji is a high-tech enterprise specializing in R & D, production and sales of minimally invasive surgical instruments and matching consumables (MISIA). It is the backbone enterprise of China Medical Endoscope Industry Base (Tonglu), the director unit of China Medical equipment Association, the director unit of China Medical device Industry Association, the vice chairman unit of Zhejiang Medical device Industry Association, and the chairman unit of Tonglu Medical device Industry Association. With the mission of "providing quality products and services for doctors and committed to the cause of human health", the Group is committed to becoming a platform for minimally invasive surgical instruments and consumables (MISIA) in China, providing one-stop solutions for minimally invasive surgery in clinical departments such as obstetrics and gynaecology, general surgery, urology and thoracic surgery through a rich product portfolio. Hangzhou Kang Infrastructure has industry-university-research platforms such as provincial academician expert workstations, provincial enterprise research institutes and enterprise high-tech research centers to develop a variety of MISIA products that meet clinical needs. The company has established a sound quality management system, and has passed ENISO 13485, ISO 9001 international quality management system certification, ISO 45001 occupational health and safety management system certification and ISO 14001 chemical management system certification. The company's main products have passed the CE certification. Through its extensive sales network, the company's products are sold to more than 3400 hospitals (including more than 1000 first-class hospitals) in China, covering all provinces, municipalities and autonomous regions of Chinese mainland, and to 42 other countries and regions at the same time.
Company Overview
The Group was founded in August 2004 in Hangzhou Kangji Medical equipment Co., Ltd. ("Hangzhou Kangji", "Company"). Hangzhou Kangji is a high-tech enterprise specializing in R & D, production and sales of minimally invasive surgical instruments and matching consumables (MISIA). It is the backbone enterprise of China Medical Endoscope Industry Base (Tonglu), the director unit of China Medical equipment Association, the director unit of China Medical device Industry Association, the vice chairman unit of Zhejiang Medical device Industry Association, and the chairman unit of Tonglu Medical device Industry Association. With the mission of "providing quality products and services for doctors and committed to the cause of human health", the Group is committed to becoming a platform for minimally invasive surgical instruments and consumables (MISIA) in China, providing one-stop solutions for minimally invasive surgery in clinical departments such as obstetrics and gynaecology, general surgery, urology and thoracic surgery through a rich product portfolio. Hangzhou Kang Infrastructure has industry-university-research platforms such as provincial academician expert workstations, provincial enterprise research institutes and enterprise high-tech research centers to develop a variety of MISIA products that meet clinical needs. The company has established a sound quality management system, and has passed ENISO 13485, ISO 9001 international quality management system certification, ISO 45001 occupational health and safety management system certification and ISO 14001 chemical management system certification. The company's main products have passed the CE certification. Through its extensive sales network, the company's products are sold to more than 3400 hospitals (including more than 1000 first-class hospitals) in China, covering all provinces, municipalities and autonomous regions of Chinese mainland, and to 42 other countries and regions at the same time.
CEO: Ming Zhong
Market: Hong Kong motherboard
Listing Date: 06/29/2020
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist